Expectations Regarding Mobility and Self-Care

Malignant Neoplasms of Independent (Primary) Multiple Sites Clinical Trial

Official title:

Assessment of Expectations Regarding Mobility and Self-Care Between Physiatrists and Oncology Patients

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02911064
• Other study ID #: 2016-0550
• Secondary ID: NCI-2018-01760
• Status: Active, not recruiting
• Start date: November 10, 2016
• Est. completion date: December 31, 2026

Study information

• Verified date: May 2024
• Source: M.D. Anderson Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this research study is to learn if there is a difference between your expectations of how well you will perform daily living activities after short-term inpatient rehabilitation and the doctor's expectations of how well you will perform daily living activities.

Description:

If you agree to take part in this study, you will complete questionnaires before your inpatient rehabilitation and after you complete inpatient rehabilitation. The questionnaires will ask about how well you currently perform daily living activities, your expectation of how well you will perform daily living activities after you complete inpatient rehabilitation, your symptoms in the past 24 hours, and your physical, functional, social, and emotional well-being. These questionnaires should take about 15 minutes total to complete.

Information from your medical record (such as your age, gender, religion, cancer diagnosis, stage of cancer, and so on) will be collected.

Length of Study:

You participation on this study will be over after you complete the questionnaires.

This is an investigational study.

Up to 111 participants will take part in this study. All will be enrolled at MD Anderson.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 133
• Est. completion date: December 31, 2026
• Est. primary completion date: December 31, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Participants are willing and able to give written informed consent and to comply with all of the study visits and surveys

2. Patients with any type of cancer admitted on the acute inpatient rehabilitation unit who can tolerate 3 hours of rehabilitation therapies per day

3. Patients 18 years and older

4. Patients must be able to understand, read, write, and speak English.

Exclusion Criteria:

1. Patients who have delirium, severe symptom distress, or cognitive impairment.

2. Patients who return to primary service prior to discharge from the acute inpatient rehabilitation unit.

Related Conditions & MeSH terms

• Benign Neoplasms
• Malignant Neoplasms of Independent (Primary) Multiple Sites
• Neoplasms

Intervention

Behavioral:
• Questionnaires
Questionnaires completed before and after inpatient rehabilitation. Questionnaires ask about daily living activity performance, expectation of how well daily living activities will be performed after completion of inpatient rehabilitation, symptoms experienced in the past 24 hours, and physical, functional, social, and emotional well-being. These questionnaires should take about 15 minutes total to complete.

Locations

Country	Name	City	State
United States	University of Texas MD Anderson Cancer Center	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessment of Participant and Physiatry Practitioner Expectations of Mobility and Activities of Daily Living After Acute Inpatient Rehabilitation Using Barthel Index		3 days
Primary	Assessment of Participant and Physiatry Practitioner Expectations of Mobility and Activities of Daily Living After Acute Inpatient Rehabilitation Using Eastern Cooperative Oncology Group (ECOG) Performance Status Scales		3 days

External Links

•   MD Anderson Cancer Center